Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
USE OF PYRIDONE DERIVATIVE
Document Type and Number:
WIPO Patent Application WO/2024/012531
Kind Code:
A1
Abstract:
A use of a pyridone derivative. A use of a substance A in preparation of a drug, wherein the substance A is a compound as shown in formula I or a pharmaceutically acceptable salt thereof; and the drug is a drug for treating and/or preventing intestinal fibrosis or non-alcoholic liver fibrosis. The substance A or the drug containing the substance A can achieve a good drug effect on intestinal fibrosis or non-alcoholic liver fibrosis at a small dosage.

Inventors:
LI YONGGUO (CN)
CHEN XIAONING (CN)
SONG HAOLIANG (CN)
LI HONGJIAO (CN)
Application Number:
PCT/CN2023/107252
Publication Date:
January 18, 2024
Filing Date:
July 13, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GUANGZHOU JOYO PHARMATECH CO LTD (CN)
International Classes:
C07D409/14; A61K31/4427; A61K31/4436; A61P1/00; A61P1/16; C07D405/04
Domestic Patent References:
WO2017177974A12017-10-19
WO2019072236A12019-04-18
WO2009149188A12009-12-10
WO2015153683A12015-10-08
Foreign References:
CN102786467A2012-11-21
CN113521072A2021-10-22
Other References:
QU SUXUAN, LIN LIANJIE, WANG DONGXU, GUO XUEYUN, ZHENG SHIHANG: "Cytokine-related Mechanisms and Therapeutic Progress of Intestinal Fibrosis", ZHONGGUO LINCHUANG YANJIU = CHINESE JOURNAL OF CLINICAL RESEARCH, ZHONGGUO LINCHUANG YANJIU BIANJIBU, CN, vol. 32, no. 1, 31 January 2019 (2019-01-31), CN , pages 111 - 115, XP009551910, ISSN: 1674-8182, DOI: 10.13429/j.cnki.cjcr.2019.01.029
LI, MI : "Research Advances in Non-alcoholic Fatty Liver Disease", JOURNAL OF MUDANJIANG MEDICAL UNIVERSITY, vol. 39, no. 4, 31 August 2018 (2018-08-31), CN , pages 101 - 104, XP009552633, ISSN: 1001-7550, DOI: 10.13799/j.cnki.mdjyxyxb.2018.04.036
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: